Pfizer (NYSE:PFE) has revealed that it has not yet performed an interim analysis for its vaccine candidate. The news — out Oct. 27 — comes after the company’s CEO Albert Bourla had repeatedly hinted that such data would be available by October. An independent data monitoring committee has a threshold for when to perform such…